News

News & Reports 2018-03-22T10:04:39+00:00

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Veana Therapeutics secures NIH funding for VIMO

Veana Therapeutics is pleased to announce a Phase I Small Business Innovation Research (SBIR) grant award from the NIH National Cancer Institute to conduct proof-of-concept pre-clinical studies of its lead product, VIMO (Veana Immune Modulator) in combination with immune checkpoint inhibitors in triple negative breast cancer. Learn more about Veana here.

November 12th, 2018|

DesignMedix Inc. wins PBJ’s Manufacturer of the Year (1-10 employees)

By Denise Szott – Contributing writer for Portland Business Journal

The Portland company developed a drug to cure malaria that is easy and cheap to manufacture

DesignMedix co-founder and Chief Scientific Officer David Peyton and a student carry out research at the DesignMedix Lab in the Portland State

 

Most of us have felt annoyed […]

November 12th, 2018|

How a $600M jolt could get OHSU’s promising AIDS vaccine to market

Elizabeth Hayes, Portland Business Journal

ANDREW TOWNSEND OHSU VACCINE & GENE THERAPY INSTITUTE

When TomegaVax Inc. spun out from Oregon Health & Science University in 2011, it had the makings of a future bio-star.

The startup would commercialize the research from the OHSU Vaccine and Gene Therapy Institute, where Dr. Louis Picker and his colleagues were developing a vaccine to combat some […]

June 15th, 2018|

Madison High graduate to attend Brown University as first-generation college student

Corlyn Vorhees, The Oregonian/Oregon Live

Madison High graduate Cynthia Bui will be attending Brown University in September.

Madison High graduate Cynthia Bui will be attending Brown University in September.

Cynthia Bui, who graduated from Madison High this week, started preparing for college when she was only 10.

She was the “really annoying know-it-all kid,” she said. “I genuinely enjoyed learning. I don’t think that’s changed. It’s gotten worse as I’ve gotten older.”

Bui learned three […]

June 11th, 2018|

Medintellibase150shaded

Progressive Democrats are pushing for a vote on a controversial health-care bill after the party takes control of the House early next year. But the left's push for "Medicare for all" l [...]

Cadent Therapeutics is coming out of stealth with a new chief medical officer and $40 million to move three of its programs into phase 2. The Cambridge, Massachusetts-based biotech is targeting ion ch [...]

Biopharma services provider Parexel is linking up with Medidata's Shyft Analytics to boost its real-world evidence offering for biopharma and medical device clients. [...]

Outgoing Maine Gov. Paul LePage (R) said Tuesday that he would consider running against Janet Mills (D), the governor elect, if she does not implement Medicaid expansion in a financially "sustain [...]

Merck kicked off a rolling FDA submission for its Ebola vaccine that's already been deployed against outbreaks in the Democratic Republic of Congo. [...]

Nektar Therapeutics has poached Genentech cancer immunotherapy leader Wei Lin, M.D., to head up its oncology program and serve as VP of clinical development as it moves forward with its phase 3 trial [...]

Nektar Therapeutics has poached Genentech cancer immunotherapy leader Wei Lin, M.D., to head up its oncology program and serve as VP of clinical development as it moves forward with its phase 3 trial [...]

Welcome to Wednesday's Overnight Health Care.Today, the next chairman of the House Energy and Commerce Committee discussed his drug pricing agenda for the next term, progressive House Democrats a [...]